Variant report
Variant | rs2525095 |
---|---|
Chromosome Location | chr17:46037277-46037278 |
allele | A/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:46019800-46047600 | Weak transcription | Aorta | Aorta |
2 | chr17:46027200-46047200 | Weak transcription | Spleen | Spleen |
3 | chr17:46027600-46047400 | Weak transcription | Right Ventricle | heart |
4 | chr17:46027600-46047600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr17:46028000-46047400 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
6 | chr17:46028000-46047600 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
7 | chr17:46030200-46045800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
8 | chr17:46031400-46039000 | Weak transcription | Primary T cells from cord blood | blood |
9 | chr17:46032000-46037800 | Active TSS | Rectal Smooth Muscle | rectum |
10 | chr17:46032800-46037800 | Enhancers | Fetal Thymus | thymus |
11 | chr17:46035000-46047400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
12 | chr17:46035200-46037600 | Weak transcription | K562 | blood |
13 | chr17:46035200-46038600 | Weak transcription | Small Intestine | intestine |
14 | chr17:46035400-46038000 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
15 | chr17:46035600-46038000 | Enhancers | Esophagus | oesophagus |
16 | chr17:46035800-46037600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr17:46035800-46037600 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
18 | chr17:46035800-46037800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr17:46035800-46037800 | Weak transcription | NHEK | skin |
20 | chr17:46036000-46047200 | Weak transcription | Stomach Smooth Muscle | stomach |
21 | chr17:46036200-46037600 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
22 | chr17:46036200-46043400 | Weak transcription | A549 | lung |
23 | chr17:46036400-46037400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
24 | chr17:46036400-46039200 | Enhancers | Pancreas | Pancrea |
25 | chr17:46036600-46037800 | Flanking Active TSS | Fetal Intestine Small | intestine |
26 | chr17:46036600-46047800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
27 | chr17:46036800-46037600 | Weak transcription | Placenta | Placenta |
28 | chr17:46036800-46038400 | Enhancers | HepG2 | liver |
29 | chr17:46036800-46047400 | Weak transcription | Thymus | Thymus |
30 | chr17:46037000-46038000 | Enhancers | Colonic Mucosa | Colon |
31 | chr17:46037000-46038400 | Weak transcription | Gastric | stomach |
32 | chr17:46037000-46038600 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
33 | chr17:46037200-46037400 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
34 | chr17:46037200-46037800 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
35 | chr17:46037200-46037800 | Flanking Active TSS | Fetal Intestine Large | intestine |
36 | chr17:46037200-46038000 | Enhancers | Placenta Amnion | Placenta Amnion |
37 | chr17:46037200-46038000 | Flanking Active TSS | Stomach Mucosa | stomach |